MTEC Announces New Funding
OREF is pleased to share this announcement from MTEC regarding available MSK research funding.
Request for Project Proposals MTEC-25-04-MultiTopic Number W81XWH-15-9-0001 13. The Medical Technology Enterprise Consortium (MTEC) is an enterprise partnership in collaboration with industry and academia to facilitate research and development activities, in cooperation with the Department of Defense (DoD) U.S. Army Medical Research and Development Command (USAMRDC), the Defense Health Agency (DHA), and other Government agencies in the biomedical sciences (including but not limited to drugs, biologics, vaccines, medical software and medical devices) to protect, treat, and optimize the health and performance of U.S. military personnel.
Focus Area 6 – Musculoskeletal Injury: Musculoskeletal injuries are the number one threat to Warfighter readiness, resulting in approximately 2.4 million medical visits and 25 million limited duty days. In the training environment, musculoskeletal injury accounts for up to 80% of causes for a Service Member being medically non-deployable significantly impacting overall combat lethality. In the deployed environment, non-battle injuries account for 30% of all medical evacuations, and more than 85% of Service Members medically evacuated for musculoskeletal injury do not return to theater. Prior musculoskeletal injury is one the biggest predictors of future musculoskeletal injury and approximately half of Service Members can expect to sustain a new musculoskeletal injury each year.
The intent of this Musculoskeletal Injury Focus Area is to find solutions of high relevance to, and focused on, the Warfighter that have the potential to be applied closer to the operational environment. For the purposes of this funding opportunity, musculoskeletal injury care encompasses multiple domains including musculoskeletal injury risk identification and mitigation; initial interventions that improve survivability and maximize ability to stay in the fight pending evacuation to definitive care; and optimization of post-musculoskeletal injury outcomes.
Proposals are due February 10, 2025. Refer to full announcement for complete details, including funding amounts.
